Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00705-021-05036-8 http://scihub22266oqcxt.onion/10.1007/s00705-021-05036-8 33745067!7980799!33745067     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Arch+Virol 2021 ; 166 (7): 1819-1840 Nephropedia Template TP {{tp|p=33745067|t=2021. The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19) |pdf=|usr=}}{{33745067}} gab.com Text The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19) JO: Arch Virol http://www.kidney.de/pget.php?&tw=1&pmid=33745067 #FOAvip COVID-19 is an acute respiratory infection accompanied by pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has affected millions of people globally. To date, there are no highly efficient therapies for this infection. Probiotic bacteria can interact with the gut microbiome to strengthen the immune system, enhance immune responses, and induce appropriate immune signaling pathways. Several probiotics have been confirmed to reduce the duration of bacterial or viral infections. Immune fitness may be one of the approaches by which protection against viral infections can be reinforced. In general, prevention is more efficient than therapy in fighting viral infections. Thus, probiotics have emerged as suitable candidates for controlling these infections. During the COVID-19 pandemic, any approach with the capacity to induce mucosal and systemic reactions could potentially be useful. Here, we summarize findings regarding the effectiveness of various probiotics for preventing virus-induced respiratory infectious diseases, especially those that could be employed for COVID-19 patients. However, the benefits of probiotics are strain-specific, and it is necessary to identify the bacterial strains that are scientifically established to be beneficial. Twit Text FOAVip The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19) ????Arch Virol http://www.kidney.de/pget.php?&tw=1&pmid=33745067 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33745067 #FOAvip English Wikipedia <ref>{{Cite pmid|33745067}}</ref> The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19) #MMPMID33745067 Mirzaei R; Attar A; Papizadeh S; Jeda AS; Hosseini-Fard SR; Jamasbi E; Kazemi S; Amerkani S; Talei GR; Moradi P; Jalalifar S; Yousefimashouf R; Hossain MA; Keyvani H; Karampoor S Arch Virol 2021[Jul]; 166 (7): 1819-1840 PMID33745067show ga COVID-19 is an acute respiratory infection accompanied by pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has affected millions of people globally. To date, there are no highly efficient therapies for this infection. Probiotic bacteria can interact with the gut microbiome to strengthen the immune system, enhance immune responses, and induce appropriate immune signaling pathways. Several probiotics have been confirmed to reduce the duration of bacterial or viral infections. Immune fitness may be one of the approaches by which protection against viral infections can be reinforced. In general, prevention is more efficient than therapy in fighting viral infections. Thus, probiotics have emerged as suitable candidates for controlling these infections. During the COVID-19 pandemic, any approach with the capacity to induce mucosal and systemic reactions could potentially be useful. Here, we summarize findings regarding the effectiveness of various probiotics for preventing virus-induced respiratory infectious diseases, especially those that could be employed for COVID-19 patients. However, the benefits of probiotics are strain-specific, and it is necessary to identify the bacterial strains that are scientifically established to be beneficial. |*COVID-19 Drug Treatment[MESH] |Antiviral Agents/pharmacology/therapeutic use[MESH] |COVID-19 Vaccines/pharmacology/therapeutic use[MESH] |COVID-19/immunology/*prevention & control[MESH] |Dysbiosis[MESH] |Humans[MESH] |Immunomodulation[MESH] |Microbiota[MESH] |Probiotics/classification/pharmacology/*therapeutic use[MESH] |SARS-CoV-2/pathogenicity[MESH]The emerging role of probiotics as a mitigation strategy against coron(epmc).pdf DeepDyve Pubget Overpricing